Steroid therapy for asthma in children

Area of Science:

• Pediatric Pulmonology
• Pharmacology
• Clinical Medicine

Background:

• Inhaled glucocorticoids (ICS) are a cornerstone in managing childhood asthma.
• Understanding their long-term impact and comparative efficacy is crucial for optimal treatment strategies.

Purpose of the Study:

• To review key studies on inhaled glucocorticoids in childhood asthma.
• To evaluate their role in early intervention, comparative efficacy, and safety.

Main Methods:

• Literature review of significant studies published on inhaled glucocorticoids in pediatric asthma.
• Analysis of research focusing on early intervention, comparison with leukotriene receptor antagonists, and systemic glucocorticoids for acute exacerbations.

Main Results:

• Early ICS intervention improves symptom control but does not alter asthma's natural history.
• Comparative studies show ICS are preferred for persistent asthma over leukotriene receptor antagonists.
• Systemic glucocorticoids are more effective than ICS for acute asthma exacerbations in children.

Conclusions:

• Inhaled glucocorticoids remain the preferred first-line controller therapy for persistent childhood asthma.
• While effective for symptom management, early ICS initiation does not prevent long-term disease progression.
• For acute asthma exacerbations, systemic glucocorticoids are superior to inhaled forms.